The Journal of Neuroscience, November 28, 2007, 27(48):13161-13172; doi:10.1523/JNEUROSCI.3974-07.2007
Previous Article | Next Article 
Neurobiology of Disease
The Down Syndrome Critical Region Protein RCAN1 Regulates Long-Term Potentiation and Memory via Inhibition of Phosphatase Signaling
Charles A. Hoeffer,1,6
Asim Dey,3
Nita Sachan,3
Helen Wong,6
Richard J. Patterson,1
John M. Shelton,3
James A. Richardson,4,5
Eric Klann,1,2,6 and
Beverly A. Rothermel3
Departments of 1Molecular Physiology and Biophysics and 2Neuroscience, Baylor College of Medicine, Houston, Texas 77030, Departments of 3Internal Medicine, 4Molecular Biology, and 5Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, and 6Center for Neural Science, New York University, New York, New York 10003
Correspondence should be addressed to Eric Klann, Center for Neural Science, 4 Washington Place, Room 809, New York University, New York, NY 10003. Email: eklann{at}cns.nyu.edu
Regulator of calcineurin 1 (RCAN1/MCIP1/DSCR1) regulates the calmodulin-dependent phosphatase calcineurin. Because it is located on human chromosome 21, RCAN1 has been postulated to contribute to mental retardation in Down syndrome and has been reported to be associated with neuronal degeneration in Alzheimer's disease. The studies herein are the first to assess the role of RCAN1 in memory and synaptic plasticity by examining the behavioral and electrophysiological properties of RCAN1 knock-out mice. These mice exhibit deficits in spatial learning and memory, reduced associative cued memory, and impaired late-phase long-term potentiation (L-LTP), phenotypes similar to those of transgenic mice with increased calcineurin activity. Consistent with this, the RCAN1 knock-out mice display increased enzymatic calcineurin activity, increased abundance of a cleaved calcineurin fragment, and decreased phosphorylation of the calcineurin substrate dopamine and cAMP-regulated phosphoprotein-32. We propose a model in which RCAN1 plays a positive role in L-LTP and memory by constraining phosphatase signaling.
Key words: calcineurin; protein phosphatase; mental retardation; hippocampus; learning and memory; synaptic plasticity
Received March 13, 2007;
revised Oct. 9, 2007;
accepted Oct. 16, 2007.
Correspondence should be addressed to Eric Klann, Center for Neural Science, 4 Washington Place, Room 809, New York University, New York, NY 10003. Email: eklann{at}cns.nyu.edu
This article has been cited by other articles:

|
 |

|
 |
 
S. Mehta, H. Li, P. G. Hogan, and K. W. Cunningham
Domain Architecture of the Regulators of Calcineurin (RCANs) and Identification of a Divergent RCAN in Yeast
Mol. Cell. Biol.,
May 15, 2009;
29(10):
2777 - 2793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ermak, K. J. Hench, K. T. Chang, S. Sachdev, and K. J. A. Davies
Regulator of Calcineurin (RCAN1-1L) Is Deficient in Huntington Disease and Protective against Mutant Huntingtin Toxicity in Vitro
J. Biol. Chem.,
May 1, 2009;
284(18):
11845 - 11853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Martinez-Martinez, L. Genesca, A. Rodriguez, A. Raya, E. Salichs, F. Were, M. D. Lopez-Maderuelo, J. M. Redondo, and S. de la Luna
The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators
PNAS,
April 14, 2009;
106(15):
6117 - 6122.
[Abstract]
[Full Text]
[PDF]
|
 |
|